NN8022-4246 In market utilisation of liraglutide used for weight management in the UK: a study in the CPRD primary care database

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  LIRAGLUTIDE
• Medical condition to be studied:
  Obesity

Population studied

• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  200

Study design details

• Main study objective:
  The aim of this study is to investigate usage of liraglutide for weight management in clinical practice using the CPRD (Clinical Practice Research Datalink) primary care database
• Outcomes:
  Acc. to protocol section 6.3.1, Acc. to study protocol section 6.3.2
• Data analysis plan:
  All data analysis will be performed by CPRD. Information from the CPRD primary care database and from the questionnaires will be used to present descriptive statistics of the proportion of patients with the endpoints of interest.